pharma · Tuberculosis
Centers for Disease
Centers for Disease Control and Prevention
Centers for Disease is a pharma organization headquartered in CN. Primary therapeutic focus areas include Tuberculosis. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
rifapentine
Phase 3 · small molecule · Tuberculosis
rifapentine for Tuberculosis is a Phase 3 program (small_molecule) at Centers for Disease Control and Prevention with 2 ClinicalTrials.gov record(s).
Internal code 6655
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Tuberculosis
- Status
- completed
- Trials
- 2